Evidence for octreotide subcutaneously in the treatment of acromegaly. - Suppr | 超能文献

Evidence for octreotide subcutaneously in the treatment of acromegaly.

作者信息

Liuzzi A, Oppizzi G

机构信息

Division of Endocrinology, Italian Auxological Centre, IRCCS St Giuseppe Hospital, Piancavallo, Italy.

出版信息

J Endocrinol. 1997 Oct;155 Suppl 1:S61-5.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Evidence for octreotide subcutaneously in the treatment of acromegaly.

J Endocrinol. 1997 Oct;155 Suppl 1:S61-5.

2

Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.新型多配体生长抑素类似物SOM230与奥曲肽在肢端肥大症患者中的药代动力学-药效学比较

Clin Pharmacol Ther. 2005 Jul;78(1):69-80. doi: 10.1016/j.clpt.2005.04.003.

3

[Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].[肢端肥大症药物治疗的当前替代方案：长效生长抑素类似物奥曲肽]

Orv Hetil. 2002 May 12;143(19 Suppl):1062-6.

4

[Treatment of therapy-resistant acromegaly using Sandostatin].[使用善宁治疗难治性肢端肥大症]

Z Gastroenterol. 1990 Sep;28 Suppl 2:29-31.

5

All aboard for octreotide.

Lancet. 1990 Oct 13;336(8720):909-11.

6

Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.奥曲肽长效注射剂的系统性剂量扩展：肢端肥大症患者个体化治疗的重要性

Clin Endocrinol (Oxf). 2004 Aug;61(2):224-31. doi: 10.1111/j.1365-2265.2004.02084.x.

7

[Experience in treating acromegalic patients with long-acting octreotide].[长效奥曲肽治疗肢端肥大症患者的经验]

Orv Hetil. 2002 May 12;143(19 Suppl):1066-70.

8

Lipoatrophy induced by subcutaneous administration of octreotide in the treatment of acromegaly.

Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):340-3. doi: 10.1055/s-2005-837664.

9

Population pharmacodynamic analysis of octreotide in acromegalic patients.肢端肥大症患者中奥曲肽的群体药效学分析。

Clin Pharmacol Ther. 2003 Jan;73(1):95-106. doi: 10.1067/mcp.2003.6.

10

Pegvisomant: new preparation. A last resort in acromegaly.培维索孟：新制剂。肢端肥大症的最后手段。

Prescrire Int. 2005 Feb;14(75):10-3.

引用本文的文献

1

Gender-related differences in growth hormone-releasing pituitary adenomas. A clinicopathological study.生长激素释放型垂体腺瘤的性别相关差异。一项临床病理研究。

Pituitary. 2002;5(4):247-53. doi: 10.1023/a:1025329900839.

2

Reevaluation of conventional pituitary irradiation in the therapy of acromegaly.肢端肥大症治疗中传统垂体放疗的重新评估

Pituitary. 1999 Jun;2(1):55-62. doi: 10.1023/a:1009969921497.